Christopher Shea to Cancer Vaccines
This is a "connection" page, showing publications Christopher Shea has written about Cancer Vaccines.
Connection Strength
0.062
-
Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901. J Immunother. 2006 Jan-Feb; 29(1):95-101.
Score: 0.062